SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject12/18/2002 10:29:55 AM
From: richardred   of 724
 
If anyone hasn't noticed. The pace of acquisitions (medical equipment- healthcare)has stepped up along with acquisitions in general. IMO it's a good sign of bottoming before a general upturn in this industry. The borrowing rate for strong companies to borrow on their line, or float new debt is very attractive. I used to own Spacelabs, but sold before it was acquired by Instrumentarium. Ditto on Ameripath (PATH). The signs are here, but a low stock price can be a driver if margins are still improving. Next quarter should be a sign of pent up demand for NBSC equipment for those with use it or loose it budgets. Also Section 179 purchases for small profitable businesses.


WAUKESHA, Wis. & HELSINKI, Finland, Dec 18, 2002 (BUSINESS WIRE) -- General Electric Company (GE) , through its GE Medical Systems division, and Instrumentarium Corporation (HEX:I1NS1V.HE) (Nasdaq:INMRY) announced today that the companies have entered into a definitive combination agreement for GE to acquire Instrumentarium. Pursuant to this agreement, GE will initiate a tender offer to acquire all of the outstanding Instrumentarium shares for EUR 40 per share payable in cash. The offer is expected to commence within 30 days.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext